ArticleMolecular pain
Copper chelator ammonium tetrathiomolybdate ameliorates the visceral hypersensitivity in dextran sulfate sodium-induced colitis mice.
Article in Molecular pain. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVisceral hypersensitivity is a prevalent and debilitating symptom in inflammatory bowel disease (IBD), severely impairing quality of life. Although mechanisms remain incompletely understood, recent studies have reported abnormal copper metabolism and elevated serum copper in IBD patients. However, whether copper homeostasis contributes to visceral hypersensitivity remains unknown.
methodsWe established a dextran sulfate sodium (DSS)-induced colitis model in C57BL/6J mice to induce visceral hypersensitivity. Copper content in the terminal colon and dorsal root ganglia (DRG) was measured using a colorimetric copper assay kit. Western blot analysis evaluated expression of central sensitization markers, calmodulin-dependent kinase II (CaMKII), phosphorylated CaMKII (p-CaMKII), cyclic adenosine monophosphate response element-binding protein (CREB), and phosphorylated CREB (p-CREB) in the spinal cord and DRG. The expression of cuproptosis-related proteins, including dihydrolipoamide S-acetyltransferase (DLAT), lipoic acid synthetase (LIAS), and ferredoxin 1 (FDX1), was also measured in the terminal colon and DRG. We examined the effects of the copper chelator ammonium tetrathiomolybdate (ATTM, 10 mg/kg, i.p., daily). Expression of copper transport ATPase copper transporting alpha (ATP7A) and copper transporter 1 (CTR1) was also assessed.
resultsDSS-induced colitis resulted in visceral hypersensitivity and central sensitization, accompanied by copper accumulation in the terminal colon and DRG, along with downregulation of DLAT, LIAS, and FDX1. ATTM reduced copper accumulation, restored cuproptosis-related protein expression, and attenuated visceral hypersensitivity and central sensitization. Notably, ATTM normalized the expression of the copper efflux transporter ATP7A and the influx transporter CTR1 in the terminal colon and DRG.
conclusionOur findings for the first time definitely identify and mechanistically elucidate that copper accumulation in the terminal colon and DRG contributes to visceral hypersensitivity in DSS-induced colitis. Dysregulation of the copper transporters ATP7A and CTR1 underlies this copper dyshomeostasis. Our results uncover copper ion homeostasis as a completely unrecognized, novel mechanistic axis driving visceral hypersensitivity in IBD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.